Virtus Pharms' Generic Levorphanol Tartrate Receives Approval in US
Virtus Pharm’s Generic Palonosetron Hydrochloride Receives Approval in the US
Generic drugmaker Virtus Pharmaceuticals recently asked the FDA in a Citizens Petition to hold up on its plan to remove unapproved generic versions of potassium chloride from the market. Now it has filed a lawsuit demanding the FDA put on the brakes.
Virtus Pharmaceuticals Opco II Recalls Virtus (Hyoscyamine Sulfate) in US after result of Superpotent and subpotent test
US FDA Enforcement report- 13/Apr/2016